Search results
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 18 hours agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Cardiff Oncology Inc (CRDF) (Q1 2024) Earnings Call Transcript Highlights: Strategic Insights ...
GuruFocus.com via Yahoo Finance· 2 hours agoThe company is leveraging Pfizer Ignite's resources to ensure effective trial execution. Q: Could you read some of the scenario planning that you...Q3/Q4 will include about ...
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 5 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 2 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 2 days agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 7 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez ...
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 14 hours agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 2 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for...
Morningstar· 7 days agoPfizer Inc. (NYSE: PFE)announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 12 hours agoIt’s important to note that the vaccine maker, which employs about 5,100 people as of June 2023 and...